Research is ongoing to understand the resistance mechanisms better and to develop novel therapies. Emerging areas include combination therapies that tackle multiple pathways simultaneously and the use of biomarkers to personalize treatment. Advances in genomics and proteomics are paving the way for more precise interventions.
